1039733-87-3

Basic information

• Product Name: N-{4-[({2-(dimethylamino)-6-[5-(dimethylamino)pyridin-2-yl]quinazolin-4-yl}amino)methyl]phenyl}-4-fluorobenzamide
• Synonyms: N-{4-[({2-(dimethylamino)-6-[5-(dimethylamino)pyridin-2-yl]quinazolin-4-yl}amino)methyl]phenyl}-4-fluorobenzamide
• CAS NO: 1039733-87-3
• Molecular Weight: 535.624
• Mol File: 1039733-87-3.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N-{4-[({2-(dimethylamino)-6-[5-(dimethylamino)pyridin-2-yl]quinazolin-4-yl}amino)methyl]phenyl}-4-fluorobenzamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-{4-[({2-(dimethylamino)-6-[5-(dimethylamino)pyridin-2-yl]quinazolin-4-yl}amino)methyl]phenyl}-4-fluorobenzamide(1039733-87-3)
• EPA Substance Registry System: N-{4-[({2-(dimethylamino)-6-[5-(dimethylamino)pyridin-2-yl]quinazolin-4-yl}amino)methyl]phenyl}-4-fluorobenzamide(1039733-87-3)

Safety Data

• Hazardous Substances Data: 1039733-87-3(Hazardous Substances Data)

Upstream product

• 1039732-64-3 N-[4-({[2-(dimethylamino)-6-iodoquinazolin-4-yl]amino}methyl)phenyl]-4-fluorobenzamide 
• 579525-46-5 6-(dimethylamino)pyridin-3-ylboronic acid 

Relevant articles and documents

AMINO-SUBSTITUTED QUINAZOLINE DERIVATIVES AS INHIBITORS OF β-CANTENIN/TCF-4 PATHWAY AND CANCER TREATMENT AGENTS

The present invention relates to amino-substituted quinazoline derivatives as inhibitors of β-catenin/tcf-4 pathway, which can be useful in the treatment of cancer; to processes for their preparation; to pharmaceutical compositions comprising them; and to methods of using them.